PBT fell from $70.2m to $32.2m on remediation and weaker investment income

Profit before tax was $32.2m versus $70.2m, and NPAT was $22.9m versus $49.7m. Management attributes the reported profit impact to customer remediation provisions. Separately, investment income roughly halved to $5.3m from $10.1m (-47.3%), a meaningful component of the year-on-year delta.

Insurance revenue eased to $291.2m from $295.8m, departing from the historical pattern of positive top-line growth (Annolyse 5-period mean +14.2%, range +1.9% to +38.5%; this comparison carries a basis-discontinuity caveat). The geographic mix flipped: the New Zealand segment result fell to $22.8m from $48.5m, while Pacific Islands rose to $7.2m from $1.2m on a benign claims experience.

Operating cash flow was $33.0m versus $57.7m. Cash on hand rose to $95.6m from $62.9m, total assets fell to $567.3m, and equity fell to $318.1m. The interim dividend was declared at 5 cents per share versus 8 cents in the prior comparable half.

PBT margin of 11.1% and NPAT margin of 7.9% both sit within Annolyse's historical normal ranges (5-period means 10.3% and 7.2%). HY25 enjoyed unusually low large-events costs, a benign claims environment, and stronger investment income, all of which raised the baseline. The reported step-down does not, on its own, indicate a structural HY26 deterioration; the underlying margin profile is intact.

Customer remediation and investment income are the disclosed drivers, but neither is sized. The release names remediation as the headline drag and the calculation pass confirms investment income halved. Together these explain a large share of the gap, yet the supplied excerpts do not quantify the remediation provision or break down the investment income decline, so the recurring versus one-off split is unclear.

Balance-sheet contraction continues. Total assets of $567.3m sit below Annolyse's historical mean of $753.2m (range $596.4m to $1.1b), and equity is down $25m. This continues a multi-period reduction in capital deployed, consistent with distribution-led capital management and the smaller post-Canterbury claims footprint.

FY25 commentary set a 5-10% gross written premium CAGR target across FY26-FY28; insurance revenue eased this half, so the target relies on second-half premium re-acceleration not visible in the half-one print.

Historically, the second half has carried less of the annual NPAT - HY25 represented 59.4% of FY25 NPAT, implying H2 was the lighter half last year - although H2 was where the bulk of FY25 operating cash flow appeared. With reported earnings already depressed by remediation, full-year arithmetic depends heavily on H2 claims experience and whether the remediation provision is finalised or recurs. Management references a "secured pipeline of revenue growth" but does not size it in the supplied material.

However, the FCF-to-NPAT ratio of 141.5% (versus 96.2% prior) is heavily flattered by capex collapsing to $0.7m from $9.9m. The HY25 base included a large intangibles outlay that did not repeat. This means the apparent cash-conversion improvement is not operating strength; it reflects a step-down in investment activity.

Operating cash flow itself fell 42.8% in absolute dollars, tracking lower reported earnings rather than diverging from them. The Pacific Islands segment's six-fold result improvement is claims-driven and inherently volatile half-to-half; stripping out that benign loss experience, the New Zealand engine produced a materially weaker outcome than the HY25 print implied. The cash balance build to $95.6m reflects timing of investment flows and lower capex more than retained earnings accumulation, which fell.

This briefing cannot assess the dollar magnitude of customer remediation, individual claims-cost or reserve movements, or solvency and capital-adequacy headroom because those are not disclosed in the supplied excerpts.